These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16759810)

  • 1. Immunoglobulin G has a role for systemic protein modulation in vivo: a new concept of protein homeostasis.
    Lee KY; Lee JS
    Med Hypotheses; 2006; 67(4):848-55. PubMed ID: 16759810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations.
    Bussone G; Dib H; Dimitrov JD; Camoin L; Broussard C; Tamas N; Guillevin L; Kaveri SV; Mouthon L
    Proteomics; 2009 Apr; 9(8):2253-62. PubMed ID: 19296548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating non-immune IgG complexes in health and disease.
    Nezlin R
    Immunol Lett; 2009 Feb; 122(2):141-4. PubMed ID: 19189847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin is a highly diverse self-molecule that improves cellular diversity and function during immune reconstitution.
    João C
    Med Hypotheses; 2007; 68(1):158-61. PubMed ID: 16890385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins.
    St-Amour I; Laroche A; Bazin R; Lemieux R
    Clin Immunol; 2009 Oct; 133(1):52-60. PubMed ID: 19604724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
    MacMillan HF; Lee T; Issekutz AC
    Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous IgG: biological modulating molecules.
    Luzi G; Bongiorno F; Paparo Barbaro S; Bruno G
    J Biol Regul Homeost Agents; 2009; 23(1):1-9. PubMed ID: 19321040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris.
    Bystryn JC; Jiao D
    Autoimmunity; 2006 Nov; 39(7):601-7. PubMed ID: 17101504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of IgG-CD4 complexes in the circulation.
    Nezlin R; Bengtsson AA
    Immunol Invest; 2008; 37(2):153-62. PubMed ID: 18300040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG.
    Aoyama Y; Nagasawa C; Nagai M; Kitajima Y
    Eur J Dermatol; 2008; 18(5):557-60. PubMed ID: 18693160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss.
    Konova E; Atanasova M; Stoykov S; Velkova A; Shoenfeld Y
    J Autoimmun; 2007 Feb; 28(1):46-54. PubMed ID: 17178213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic modulation of anaphylactic shock: plasma proteins influence.
    Nezhinskaya GI; Vladykin AL; Sapronov NS
    Life Sci; 2007 May; 80(24-25):2342-6. PubMed ID: 17499313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the cellular immune system by intravenous immunoglobulin.
    Tha-In T; Bayry J; Metselaar HJ; Kaveri SV; Kwekkeboom J
    Trends Immunol; 2008 Dec; 29(12):608-15. PubMed ID: 18926775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
    Atkins KL; Burman JD; Chamberlain ES; Cooper JE; Poutrel B; Bagby S; Jenkins AT; Feil EJ; van den Elsen JM
    Mol Immunol; 2008 Mar; 45(6):1600-11. PubMed ID: 18061675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R; Saikali P; Vincent T
    Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J; Ebata R; Jibiki T; Yasukawa K; Saito H; Terai M
    J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
    Bazin R; Lemieux R; Tremblay T
    Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
    Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus.
    Khan F; Siddiqui AA; Ali R
    Scand J Immunol; 2006 Nov; 64(5):507-14. PubMed ID: 17032243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.